Suppression of HAS2 in MDA-MB-231 breast cancer cell line displayed decreased cellular proliferation with a transient arrest in a cell cycle, ablation of migratory phenotype, alteration in hyaluronan catabolism, and inhibition of primary and secondary tumour formation [14]. This evidence concerns the gene HAS2 and breast cancer.